BCR-RET Recombinant Human Active Protein Kinase
BCR-RET Recombinant Human Active Protein Kinase is a BCR-RET fusion protein in hematopoietic malignancies. BCR-RET overactivates the Ras-ERK pathway, in addition to JAK/STAT3 and PI3K/AKT pathways[1].
Product Specifications
UNSPSC
12352211
Target
RET
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Others
Smiles
[BCR-RETRecombinantHumanActiveProteinKinase]
References & Citations
[1]Peiris MN, et al. BCR: a promiscuous fusion partner in hematopoietic disorders. Oncotarget. 2019 Apr 12;10 (28) :2738-2754.
Shipping Conditions
Room temperature
Scientific Category
Enzyme
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
